279 related articles for article (PubMed ID: 20095887)
21. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Terzoudis S; Malliaraki N; Damilakis J; Dimitriadou DA; Zavos C; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):814-9. PubMed ID: 26934527
[TBL] [Abstract][Full Text] [Related]
22. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.
Döcke S; Lock JF; Birkenfeld AL; Hoppe S; Lieske S; Rieger A; Raschzok N; Sauer IM; Florian S; Osterhoff MA; Heller R; Herrmann K; Lindenmüller S; Horn P; Bauer M; Weickert MO; Neuhaus P; Stockmann M; Möhlig M; Pfeiffer AF; von Loeffelholz C
Eur J Endocrinol; 2013 Nov; 169(5):547-57. PubMed ID: 23935128
[TBL] [Abstract][Full Text] [Related]
23. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
24. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
Hatziagelaki E; Herder C; Tsiavou A; Teichert T; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M
PLoS One; 2015; 10(5):e0124935. PubMed ID: 25933030
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes.
Kukla M; Menżyk T; Dembiński M; Winiarski M; Garlicki A; Bociąga-Jasik M; Skonieczna M; Hudy D; Maziarz B; Kusnierz-Cabala B; Skladany L; Grgurevic I; Wójcik-Bugajska M; Grodzicki T; Stygar D; Rogula T
Sci Rep; 2021 Nov; 11(1):21514. PubMed ID: 34728695
[TBL] [Abstract][Full Text] [Related]
26. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
Jamali R; Arj A; Razavizade M; Aarabi MH
Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
Motawi TMK; Mahdy SG; El-Sawalhi MM; Ali EN; El-Telbany RFA
Can J Physiol Pharmacol; 2018 Jan; 96(1):38-44. PubMed ID: 28957639
[TBL] [Abstract][Full Text] [Related]
28. Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease.
Zwolak A; Szuster-Ciesielska A; Daniluk J; Semeniuk J; Kandefer-Szerszen M
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):862-869. PubMed ID: 27740519
[TBL] [Abstract][Full Text] [Related]
29. [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes].
Zhang L; Gao XF; Wang YH
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2407-2413. PubMed ID: 30138985
[No Abstract] [Full Text] [Related]
30. Adipokines and cytokines in non-alcoholic fatty liver disease.
Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
[TBL] [Abstract][Full Text] [Related]
31. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
Kumar R; Prakash S; Chhabra S; Singla V; Madan K; Gupta SD; Panda SK; Khanal S; Acharya SK
Indian J Med Res; 2012 Aug; 136(2):229-36. PubMed ID: 22960889
[TBL] [Abstract][Full Text] [Related]
32. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Ballestri S; Nascimbeni F; Romagnoli D; Lonardo A
Hepatol Res; 2016 Oct; 46(11):1074-1087. PubMed ID: 26785389
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Zhuang X; Sun F; Li L; Jiang D; Li X; Sun A; Pan Z; Lou N; Zhang L; Lou F
Clin Lab; 2015; 61(10):1409-14. PubMed ID: 26642701
[TBL] [Abstract][Full Text] [Related]
34. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
[TBL] [Abstract][Full Text] [Related]
35. Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome.
Ouwens DM; Bekaert M; Lapauw B; Van Nieuwenhove Y; Lehr S; Hartwig S; Calders P; Kaufman JM; Sell H; Eckel J; Ruige JB
Arch Physiol Biochem; 2012 Jul; 118(3):135-8. PubMed ID: 22335466
[TBL] [Abstract][Full Text] [Related]
36. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
37. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO
Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196
[TBL] [Abstract][Full Text] [Related]
38. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
Wang LY; Wei L; Yu HY; Zhang Y; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838
[TBL] [Abstract][Full Text] [Related]
39. Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.
Kajor M; Kukla M; Waluga M; Liszka Ł; Dyaczyński M; Kowalski G; Żądło D; Berdowska A; Chapuła M; Kostrząb-Zdebel A; Bułdak RJ; Sawczyn T; Hartleb M
Pol J Pathol; 2017; 68(2):117-127. PubMed ID: 29025245
[TBL] [Abstract][Full Text] [Related]
40. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
